182 related articles for article (PubMed ID: 33189983)
1. Occult lymph node metastases in clinical N0/N1 NSCLC; A single center in-depth analysis.
Beyaz F; Verhoeven RLJ; Schuurbiers OCJ; Verhagen AFTM; van der Heijden EHFM
Lung Cancer; 2020 Dec; 150():186-194. PubMed ID: 33189983
[TBL] [Abstract][Full Text] [Related]
2. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
[TBL] [Abstract][Full Text] [Related]
3. Occult lymph node metastasis in radiologic stage I non-small cell lung cancer: The role of endobronchial ultrasound.
Kukhon FR; Lan X; Helgeson SA; Arunthari V; Fernandez-Bussy S; Patel NM
Clin Respir J; 2021 Jun; 15(6):676-682. PubMed ID: 33630405
[TBL] [Abstract][Full Text] [Related]
4. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
[TBL] [Abstract][Full Text] [Related]
5. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
6. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
7. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography.
Ong P; Grosu H; Eapen GA; Rodriguez M; Lazarus D; Ost D; Jimenez CA; Morice R; Bandi V; Tamara L; Cornwell L; Green L; Zhu A; Casal RF
Ann Am Thorac Soc; 2015 Mar; 12(3):415-9. PubMed ID: 25584815
[TBL] [Abstract][Full Text] [Related]
9. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
10. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
[TBL] [Abstract][Full Text] [Related]
11. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
[TBL] [Abstract][Full Text] [Related]
12. Negative EBUS-TBNA Predicts Very Low Prevalence of Mediastinal Disease in Staging of Non-Small Cell Lung Cancer.
Taverner J; Cheang MY; Antippa P; See K; Irving LB; Steinfort DP
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):177-80. PubMed ID: 26905440
[TBL] [Abstract][Full Text] [Related]
13. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
[TBL] [Abstract][Full Text] [Related]
14. Is it necessary to sample the contralateral nodal stations by EBUS-TBNA in patients with lung cancer and clinical N0 / N1 on PET-CT?
Serra P; Centeno C; Sanz-Santos J; Torky M; Baeza S; Mendiluce L; Martínez-Barenys C; López de Castro P; Abad J; Rosell A; Andreo F
Lung Cancer; 2020 Apr; 142():9-12. PubMed ID: 32062200
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Kaseda K; Asakura K; Kazama A; Ozawa Y
World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
Aktas GE; Karamustafaoğlu YA; Balta C; Süt N; Sarikaya İ; Sarikaya A
Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
[TBL] [Abstract][Full Text] [Related]
17. Pathological N1/N2 in Clinical Stage I Bronchogenic Carcinoma. Analysis From a Prospective Multicentre Database.
Romero Román A; Crowley Carrasco S; Gil Barturen M; Royuela A; Obiols C; Call S; Recuero JL; Royo Í; Embún R; Gómez de Antonio D;
Arch Bronconeumol; 2023 Jun; 59(6):364-369. PubMed ID: 37005150
[TBL] [Abstract][Full Text] [Related]
18. Endobronchial ultrasound-guided transbronchial needle aspiration for differentiating N0 versus N1 lung cancer.
Yasufuku K; Nakajima T; Waddell T; Keshavjee S; Yoshino I
Ann Thorac Surg; 2013 Nov; 96(5):1756-60. PubMed ID: 23953728
[TBL] [Abstract][Full Text] [Related]
19. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
[TBL] [Abstract][Full Text] [Related]
20. Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.
Robson JM; Vaidyanathan S; Cheyne L; Snee M; Franks K; Callister ME
Clin Lung Cancer; 2014 Nov; 15(6):466-9. PubMed ID: 25220208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
